Peter Bryden is a seasoned health economist currently serving as the Director of Value and Access NMD Intercontinental at Biogen. Prior to this role, they held positions at Roche as Health Economist and Evidence Synthesis Leader for Global Access, and at Oxford Outcomes, where they designed cost-effectiveness models and contributed to health technology assessments. Peter's academic background includes a Bachelor's degree in Mathematics from King's College London and a Master's degree in Medical Statistics from the University of Leicester. Their experience spans various aspects of economic evaluation and market access strategy development in the healthcare sector.
This person is not in the org chart
This person is not in any teams
This person is not in any offices